Back to Journals » OncoTargets and Therapy » Volume 7

Original Research

Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia

       
Total article views   HTML views PDF downloads Totals
13,669 Dovepress* 12,771+ 1,537 14,308
PubMed Central* 898 409 1,307
Totals 13,669 1,946 15,615
*Since 26 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar